|
Thu, 03/20/2025 - 19:04 |
Caris Life Sciences Publishes Study Featuring the Largest Real-World Cohort of Tissue-Agnostic Indications Revealing Over 20 Percent of Patients Are Eligible for Pan-Cancer Therapies |
Caris Life Sciences |
|
Wed, 03/19/2025 - 18:04 |
Vermont Cancer Advocates Convene at State House to Urge Lawmakers to Expand Access to Biomarker Testing |
ACS CAN |
|
Wed, 03/19/2025 - 18:03 |
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing |
ACS CAN |
|
Tue, 03/04/2025 - 19:12 |
HORIBA Announces New Veloci BioPharma Analyzer for Biopharma and Pharma Applications |
HORIBA |
|
Wed, 01/29/2025 - 17:39 |
Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways |
Debiopharm Group |
|
Sat, 01/18/2025 - 06:45 |
New Study Shows Cancer Rates Rising in Women; Advocates Urge Hawaii State Lawmakers to Support Cancer Fight in 2025 |
ACS CAN |
|
Thu, 01/16/2025 - 17:34 |
Back Caris Life Sciences Announces a Strategic Collaboration with Ontada to Advance Oncology Research and the Adoption of Precision Medicine |
Caris Life Sciences |
|
Tue, 08/06/2024 - 08:17 |
Illumina launches new oncology menu for NovaSeq X Series customers |
Illumina |
|
Fri, 07/05/2024 - 21:48 |
Veterinary Diagnostics Company MI:RNA Raises $4 million Series A Funding |
Elmwood College |
|
Thu, 06/27/2024 - 17:03 |
The Caris Precision Oncology Alliance Welcomes Leading Cancer Center |
Caris Life Sciences |
|
Thu, 05/30/2024 - 20:24 |
Lamont Signs into Law Legislation to Remove Barriers to Biomarker Testing |
ACS CAN |
|
Tue, 04/30/2024 - 20:03 |
Caris Life Sciences and COTA, Inc. Announce Collaboration to Expand Collective Multi-Modal Data Offering |
Caris Life Sciences |
|
Thu, 04/04/2024 - 03:07 |
New European Consortium to Develop Non-Invasive Home Diagnostic Tests for Hormonal Disorders |
IQBIOZOOM |
|
Wed, 02/07/2024 - 18:22 |
Virgin Pulse and HealthComp introduce combined company as Personify Health |
Virgin Pulse |
|
Wed, 07/06/2022 - 09:33 |
Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein |
KaloBios Pharma... |
|
Wed, 06/01/2022 - 23:05 |
Labcorp Expands Access to Comprehensive Genomic Testing Through New Lung Cancer Program |
LabCorp |
|
Tue, 03/15/2022 - 06:27 |
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe |
Illumina |
|
Thu, 03/03/2022 - 23:20 |
Verification Testing Started with AI Startup Epistra for Joint Development of Solution for Optimizing Cell Culturing Parameters |
Shimadzu |
|
Wed, 12/08/2021 - 19:57 |
Illumina Supports Norway's Pioneering Precision Medicine Study |
Illumina |
|
Fri, 09/24/2021 - 04:26 |
Timme-Laragy to Investigate Effects of Environmental Toxicants on Pancreatic Development |
University of M... |
|
Wed, 09/15/2021 - 00:22 |
Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer |
Biodesix |
|
Wed, 09/01/2021 - 12:59 |
CLS FAST Program Comes to Southern California |
CLSA |
|
Wed, 09/01/2021 - 12:48 |
FAST Program to Support Five Startups from Southern California |
CLSA |
|
Tue, 08/03/2021 - 07:15 |
Shimadzu and HORIBA to Collaborate on Development and Sales of LC-Raman Analytical and Measuring Instruments |
HORIBA |
|
Thu, 07/29/2021 - 21:36 |
19/07/2021: Theradiag reports revenue of 5.5 million for the first half of 2021, up 12.5% |
Theradiag |
